Gregory Scott Duncan Cor Medix Inc. (CRMD) insider trading activity

Gregory Scott Duncan is Director of CorMedix Inc.. Currently has a direct ownership of 38,333 shares of CRMD, which is worth approximately $429,329. The most recent transaction as insider was on Sep 16, 2025, when has been sold 13,333 shares (Common Stock) at a price of $8.32 per share, resulting in proceeds of $110,930. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.3K

53.33% 3M change

n/a 12M change

Total Value Held $429,329

Gregory Scott Duncan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 16 2025	BUY Exercise of conversion of derivative security	$110,930 $8.32 p/Share	13,333 Added 25.81%	38,333 Common Stock
Jan 17 2025	BUY Grant, award, or other acquisition	-	25,000 Added 50.0%	25,000 Common Stock

Also insider at

VIRI

Virios Therapeutics, Inc. Healthcare

CHIEF EXECUTIVE OFFICER

GSD